CHRO Insider Trading Activity and SEC Form 4 Filings
CHRO insider trading summary
No open-market insider purchases or sales of Chromocell Therapeutics Corp (CHRO) have been reported on SEC Form 4 in the past 12 months.
Latest CHRO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 13, 2024 | Knuettel Francis II | CEO, Pres., CFO, Treas & Secty | Buy | $3K (3,500 @ $0.97) |
| Sep 12, 2024 | Knuettel Francis II | CEO, Pres., CFO, Treas & Secty | Buy | $2K (1,700 @ $0.97) |
| Sep 12, 2024 | Richard Malamut | Director | Buy | $10K (10,400 @ $0.94) |
| Sep 11, 2024 | Knuettel Francis II | CEO, Pres., CFO, Treas & Secty | Buy | $5K (5,500 @ $0.94) |
| Sep 10, 2024 | Knuettel Francis II | CEO, Pres., CFO, Treas & Secty | Buy | $6K (6,500 @ $0.89) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.